Paolo Gavarotti

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani et al. · Journal of Clinical Oncology · 2018 · 193 citations

Early chemotherapy intensification with BEACOPP in advanced‐stage Hodgkin lymphoma patients with a interim‐PET positive after two ABVD courses

Andrea Gallamini, Caterina Patti, Simonetta Viviani et al. · British Journal of Haematology · 2010 · 135 citations · Full text

Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy

Mario Boccadoro, Paolo Gavarotti, Giorgio Fossati et al. · British Journal of Haematology · 1984 · 89 citations

VEPEMB in elderly Hodgkin’s lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study

Alessandro Levis, Alessandro Anselmo, Alberto Ambrosetti et al. · Annals of Oncology · 2003 · 83 citations · Full text

Lymphoid Neoplasia, Medicine, Immunodeficiencies +8

Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study

Giovannino Ciccone, Dario Mirabelli, Alessandro Levis et al. · Cancer Genetics and Cytogenetics · 1993 · 69 citations

Hematological Malignancy, Hematology, Chemical Exposure +6